A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Manyando, Christine ^a   Kayentao, Kassoum ^b   Dalessandro, Umberto ^c,d   Okafor, Henrietta U ^e   Juma, Elizabeth ^f   Hamed, Kamal ^g  

^a TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^b Malaria Research and Training Centre   (Mali)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e UNIVERSITY OF NIGERIA   (Nigeria)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^g NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Artemether lumefantrine; Artemisinin based combination therapy (ACT); Malaria; Plasmodium falciparum; Pregnancy

Indexed keywords

ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLORPROGUANIL PLUS DAPSONE; CLINDAMYCIN; MEFLOQUINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

CONGENITAL DISORDER; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; LOW BIRTH WEIGHT; MALARIA FALCIPARUM; NEWBORN DEATH; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; REVIEW; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; WORLD HEALTH ORGANIZATION; COMPARATIVE STUDY; DRUG COMBINATION; DRUG TOXICITY; PREGNANCY COMPLICATION; TREATMENT OUTCOME;

ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; DRUG TOXICITY; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA, FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRIMETHAMINE; QUININE; SULFADOXINE; TREATMENT OUTCOME;

EID: 84862185178     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-141     Document Type: Review

References (61)

1. Malaria in pregnancy. Whitty CJ, Edmonds S, Mutabingwa TK, BJOG 2005 112 1189 1195 10.1111/j.1471-0528.2005.00714.x 16101595 (Pubitemid 43960913)
2. The contribution of malaria in pregnancy to perinatal mortality. van Geertruyden JP, Thomas F, Erhart A, D'Alessandro U, Am J Trop Med Hyg 2004 71 35 40 15331817 (Pubitemid 39121302)
3. An autopsy study of maternal mortality in Mozambique: the contribution of infectious diseases. Menendez C, Romagosa C, Ismail MR, Carrilho C, Saute F, Osman N, Machungo F, Bardaji A, Quinto L, Mayor A, Naniche D, Dobão C, Alonso PL, Ordi J, PLoS Med 2008 5 44 10.1371/journal.pmed.0050044 18288887 (Pubitemid 351317653)
4. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO, PLoS Med 2010 7 1000221 10.1371/journal.pmed.1000221 20126256
5. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, van Eijk AM, Rogerson SJ, Steketee RW, Am J Trop Med Hyg 2004 71 41 54 15331818 (Pubitemid 39121303)
6. Assessment of the safety of artemisinin compounds in pregnancy. WHO, http://www.who.int/malaria/publications/atoz/9789241596114/en/index.html
7. Case management of malaria in pregnancy. Nosten F, McGready R, Mutabingwa T, Lancet Infect Dis 2007 7 118 125 10.1016/S1473-3099(07)70023-3 17251082 (Pubitemid 46137945)
8. Impact of malaria at the end of pregnancy on infant mortality and morbidity. Bardaji A, Sigauque B, Sanz S, Maixenchs M, Ordi J, Aponte JJ, Mabunda S, Alonso PL, Menendez C, J Infect Dis 2011 203 691 699 10.1093/infdis/jiq049 21199881
9. World Malaria Report 2010. WHO, http://www.who.int/malaria/world-malaria- report-2010/en/index.html
10. Artemisinin-based combination therapy for treating uncomplicated malaria. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P, Cochrane Database Syst Rev 2009 D007483
11. Guidelines for the Treatment of Malaria: Second Edition (2010). WHO, http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html
12. Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count. Clark RL, Lerman SA, Cox EM, Gristwood WE, White TE, Birth Defects Res B Dev Reprod Toxicol 2008 83 397 406 10.1002/bdrb.20165 18702118
13. Sensitive periods for developmental toxicity of orally administered artesunate in the rat. White TE, Clark RL, Birth Defects Res B Dev Reprod Toxicol 2008 83 407 417 10.1002/bdrb.20157 18615704
14. The safety of artemisinins during pregnancy: a pressing question. Dellicour S, Hall S, Chandramohan D, Greenwood B, Malar J 2007 6 15 10.1186/1475-2875-6-15 17300719
15. Randomised trial of artemether versus artemether and mefloquine for the treatment of chloroquine/sufadoxine-pyrimethamine-resistant falciparum malaria during pregnancy. Sowunmi A, Oduola AM, Ogundahunsi OA, Fehintola FA, Ilesanmi OA, Akinyinka OO, Arowojolu AO, J Obstet Gynaecol 1998 18 322 327 10.1080/01443619867038 15512100 (Pubitemid 28310300)
16. Artemether in the treatment of falciparum malaria during pregnancy in eastern Sudan. Adam I, Elwasila E, Mohammed Ali DA, Elansari E, Elbashir MI, Trans R Soc Trop Med Hyg 2004 98 509 513 10.1016/j.trstmh.2003.11.008 15251398 (Pubitemid 38987085)
17. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. McGready R, Cho T, Keo NK, Thwai KL, Villegas L, Looareesuwan S, White NJ, Nosten F, Clin Infect Dis 2001 33 2009 2016 10.1086/324349 11712093 (Pubitemid 33152395)
18. Artemisinin derivatives in the treatment of falciparum malaria in pregnancy. McGready R, Cho T, Cho JJ, Simpson JA, Luxemburger C, Dubowitz L, Looareesuwan S, White NJ, Nosten F, Trans R Soc Trop Med Hyg 1998 92 430 433 10.1016/S0035-9203(98)91081-1 9850401 (Pubitemid 28409894)
19. The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy. McGready R, Nosten F, Ann Trop Med Parasitol 1999 93 Suppl 1 19 S23 10715685
20. Follow-up observation on the therapeutic effects and remote reactions of artemisinin (Qinghaosu) and artemether in treating malaria in pregnant woman. Wang TY, J Tradit Chin Med 1989 9 28 30 2761279
21. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. McGready R, Stepniewska K, Lindegardh N, Ashley EA, La Y, Singhasivanon P, White NJ, Nosten F, Eur J Clin Pharmacol 2006 62 1021 1031 10.1007/s00228-006-0199-7 17053895 (Pubitemid 44786494)
22. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy. McGready R, Tan SO, Ashley EA, Pimanpanarak M, Viladpai-Nguen J, Phaiphun L, Wustefeld K, Barends M, Laochan N, Keereecharoen L, Lindegardh N, Singhasivanon P, White NJ, Nosten F, PLoS Med 2008 5 253 10.1371/journal.pmed.0050253 19265453
23. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda. Kaye DK, Nshemerirwe R, Mutyaba TS, Ndeezi G, J Infect Dev Ctries 2008 2 135 139 10.3855/T2.2.135 19738339
24. Safety of artemisinins during early pregnancy, assessed in 62 Sudanese women. Adam I, Elhassan EM, Omer EM, Abdulla MA, Mahgoub HM, Adam GK, Ann Trop Med Parasitol 2009 103 205 210 10.1179/136485909X398285 19341535
25. Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Piola P, Nabasumba C, Turyakira E, Dhorda M, Lindegardh N, Nyehangane D, Snounou G, Ashley EA, McGready R, Nosten F, Guerin PJ, Lancet Infect Dis 2010 10 762 769 10.1016/S1473-3099(10)70202-4 20932805
26. Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, Njunju E, Gomes M, Ribeiro I, Walter V, Virtanen M, Schlienger R, Cousin M, Chipimo M, Sullivan FM, Malar J 2010 9 249 10.1186/1475-2875-9-249 20809964
27. Patterns of anti-malarial drug treatment among pregnant women in Uganda. Sangare LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Stergachis A, Malar J 2011 10 152 10.1186/1475-2875-10-152 21645402
28. Antimalarial chlorproguanil-dapsone (LapDap) withdrawn following demonstration of post-treatment haemolytic anaemia in G6PD deficient patients in a phase III trial of chlorproguanil-dapsone-artesunate (Dacart) versus artemether-lumefantrine (Coartem) and confirmation of findings in a comparative trial of LapDap versus Dacart WHO, http://www.who.int/medicines/publications/ drugalerts/Alert-117-LapDap.pdf
29. Parasitological efficacy of antimalarials in the treatment and prevention of falciparum malaria in pregnancy 1998 to 2009: a systematic review. McGready R, White NJ, Nosten F, BJOG 2011 118 123 135 10.1111/j.1471-0528.2010.02810.x 21159117
30. Pharmacokinetics of antimalarials in pregnancy: a systematic review. Wilby KJ, Ensom MH, Clin Pharmacokinet 2011 50 705 723 10.2165/11594550- 000000000-00000 21973268
31. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria. Ashley EA, Stepniewska K, Lindegardh N, McGready R, Annerberg A, Hutagalung R, Singtoroj T, Hla G, Brockman A, Proux S, Wilahphaingern J, Singhasivanon P, White NJ, Nosten F, Trop Med Int Health 2007 12 201 208 10.1111/j.1365-3156.2006.01785.x 17300626
32. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ, Antimicrob Agents Chemother 2000 44 697 704 10.1128/AAC.44.3.697-704.2000 10681341 (Pubitemid 30117964)
33. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP, Lancet 2005 365 1467 1473 10.1016/S0140- 6736(05)66416-1 15850630 (Pubitemid 40591691)
34. A clinical and pharmacokinetic trial of six doses of artemether- lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Lefèvre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R, Am J Trop Med Hyg 2001 64 247 256 11463111
35. Pharmacokinetic interaction trial between co-artemether and mefloquine. Lefèvre G, Bindschedler M, Ezzet F, Schaeffer N, Meyer I, Thomsen MS, Eur J Pharm Sci 2000 10 141 151 10.1016/S0928-0987(00)00060-9 10727880 (Pubitemid 30155936)
36. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects. Lefèvre G, Carpenter P, Souppart C, Schmidli H, Martin JM, Lane A, Ward C, Amakye D, J Clin Pharmacol 2002 42 1147 1158 12362930
37. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria. Tarning J, McGready R, Lindegardh N, Ashley EA, Pimanpanarak M, Kamanikom B, Annerberg A, Day NP, Stepniewska K, Singhasivanon P, White NJ, Nosten F, Antimicrob Agents Chemother 2009 53 3837 3846 10.1128/AAC.00195-09 19564366
38. Epidemiology and burden of malaria in pregnancy. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD, Lancet Infect Dis 2007 7 93 104 10.1016/S1473-3099(07)70021-X 17251080 (Pubitemid 46123132)
39. Global report on antimalarial drug efficacy and drug resistance: 2000-2010. WHO, http://www.who.int/malaria/publications/atoz/9789241500470/en/ index.html
40. Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients. Clark RL, Birth Defects Res A Clin Mol Teratol 2012 94 61 75 10.1002/bdra.22868 22125126
41. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. McGready R, Lee SJ, Wiladphaingern J, Ashley EA, Rijken MJ, Boel M, Simpson JA, Paw MK, Pimanpanarak M, Mu O, Singhasivanon P, White NJ, Nosten FH, Lancet Infect Dis 2011 10.1016/S1473-3099(11)70339-5
42. Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries. Dellicour S, ter Kuile FO, Stergachis A, PLoS Med 2008 5 187 10.1371/journal.pmed.0050187 18788893
43. Implementation of the Zambia electronic perinatal record system for comprehensive prenatal and delivery care. Chi BH, Vwalika B, Killam WP, Wamalume C, Giganti MJ, Mbewe R, Stringer EM, Chintu NT, Putta NB, Liu KC, Chibwesha CJ, Rouse DJ, Stringer JS, Int J Gynaecol Obstet 2011 113 131 136 10.1016/j.ijgo.2010.11.013 21315347
44. The clinical efficacy of artemether/lumefantrine (Coartem). Makanga M, Krudsood S, Malar J 2009 8 Suppl 1 5 10.1186/1475-2875-8-S1-S5 19917075
45. Understanding the pharmacokinetics of Coartem. Djimde A, Lefevre G, Malar J 2009 8 Suppl 1 4 10.1186/1475-2875-8-S1-S4 19917074
46. Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC. Onyamboko MA, Meshnick SR, Fleckenstein L, Koch MA, Atibu J, Lokomba V, Douoguih M, Hemingway-Foday J, Wesche D, Ryder RW, Bose C, Wright LL, Tshefu AK, Capparelli EV, Malar J 2011 10 49 10.1186/1475-2875-10-49 21352601
47. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria. Morris CA, Onyamboko MA, Capparelli E, Koch MA, Atibu J, Lokomba V, Douoguih M, Hemingway-Foday J, Wesche D, Ryder RW, Morris CA, Onyamboko MA, Capparelli E, Koch MA, Atibu J, Malar J 2011 10 114 10.1186/1475-2875-10-114 21548983
48. Malaria in pregnancy consortium: Pharmacokinetic Studies. http://www.mip-consortium.org/projects/pharmacokinetics.htm
49. Update on the efficacy, effectiveness and safety of artemether- lumefantrine combination therapy for treatment of uncomplicated malaria. Byakika-Kibwika P, Lamorde M, Mayanja-Kizza H, Merry C, Colebunders B, van Geertruyden JP, Ther Clin Risk Manag 2010 6 11 20 20169032
50. Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin. Birku Y, Mekonnen E, Bjorkman A, Wolday D, Ethiop Med J 2002 40 Suppl 1 17 26 12802828
51. Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers. German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N, Aweeka FT, J Acquir Immune Defic Syndr 2009 51 424 429 10.1097/QAI.0b013e3181acb4ff 19506482
52. South Africa National Department of Health, Guidelines for the treatment of malaria in South Africa http://www.kznhealth.gov.za/medicine/ 2009malariaguideline.pdf
53. President's Malaria Initiative: Malaria Operational Plan (MOP)-FY2011 Ethiopia. http://www.fightingmalaria.gov/countries/mops/fy11/ethiopia-mop-fy11. pdf
54. Highly effective therapy for malaria in pregnancy improves maternal and neonatal health outcome [abstract]. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Sugiarto P, Tjitra E, Anstey NM, Price RN, Am J Trop Med Hyg 2011 85 Suppl 6 bstract number 455
55. WHO, Country antimalarial drug policies: by region WHO African Region http://www.who.int/malaria/am-drug-policies-by-region-afro/en/index.html
56. Roll Back Malaria Partnership: 2005 China Country Profile. http://www.rollbackmalaria.org/wmr2005/profiles/china.pdf
57. Roll Back Malaria Partnership: 2005 Thailand Country Profile. http://www.rollbackmalaria.org/wmr2005/profiles/thailand.pdf
58. Ugandan Malaria Control Programme, Ugandan National Policy on Malaria 2005 http://www.health.go.ug/mcp/NationalPolicyonMalariaTreatment(07-03-06).pdf
59. Malaria in South Sudan 4: treatment of uncomplicated P. falciparum malaria. Azairwe R, Achan J, Southern Sudan Medical Journal 2011 4 30 32
60. WHO, Country antimalarial drug policies by region WHO Western Pacific Region http://www.who.int/malaria/am-drug-policies-by-regio-wpro/en/index.html
61. Drugs for treating uncomplicated malaria in pregnant women. Orton LC, Omari AA, Cochrane Database Syst Rev 2008, CD004912.